<?xml version="1.0" encoding="UTF-8"?>
<p>The GII.4_Sydney lineage emerged in 2012, and still causes a large number of cases. In 2016, the variant GII.4_Sydney recombined in association with a novel GII.P16 ORF1, and the circulation of this variant increased in many countries such as Germany, South Korea and United States (
 <xref rid="B8" ref-type="bibr">Choi et al., 2017</xref>; 
 <xref rid="B35" ref-type="bibr">Niendorf et al., 2017</xref>; 
 <xref rid="B1" ref-type="bibr">Barclay et al., 2019</xref>). In Brazil, this novel variant was identified in 59.5% (22/37) of genetically characterized samples (
 <xref rid="B2" ref-type="bibr">Barreira et al., 2017</xref>). Additionally, the increase in norovirus activity at the end of 2016 to 2017 may have occurred because of the emergent GII.P16/GII.2 recombinant (
 <xref rid="B17" ref-type="bibr">Fu et al., 2017</xref>; 
 <xref rid="B24" ref-type="bibr">Kwok et al., 2017</xref>; 
 <xref rid="B28" ref-type="bibr">Liu et al., 2017</xref>). This GII.P16 genotype presented several amino acid changes in non-structural proteins, such as RdRp, and these changed seemed to facilitate its transmission (
 <xref rid="B5" ref-type="bibr">Cannon et al., 2017</xref>; 
 <xref rid="B51" ref-type="bibr">Tohma et al., 2017</xref>; 
 <xref rid="B7" ref-type="bibr">Cheung et al., 2019</xref>). In this study, we analyzed the complete genomes of GII.4 strains collected over 5 years to understand their genetic characteristics and investigate the emergence of GII.P16/GII.4.
</p>
